ConductScience.org, home

Cell line · CVCL_0426

MG-63

Cancer cell line, Homo sapiens. Osteosarcoma. 81 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. MG-63. Cell lines, record CVCL_0426. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0426

On this page

Cell line

As Cellosaurus gives it.

Name
MG-63
Accession
CVCL_0426
RRID
RRID:CVCL_0426
Synonyms
M-G63, MG63
Species
Homo sapiens (Human)
Sex
Male
Age at sampling
14Y
Category
Cancer cell line
Diseases
Osteosarcoma (NCIt C9145); Osteosarcoma (ORDO Orphanet_668)
Derived from
Bone, left femur (metastatic)
Entry created
2012-04-04
Entry updated
2025-04-10

Source Cellosaurus

Problems1

ProblemCellosaurus's note
CautionThe reported STR profile from CLS of this cell line was changed in June 2019. Seven conflicts with other sources were resolved.

Papers81

PaperJournalYearHow we knowRetractedSource
Surface modification of 3D‐printed polycaprolactone scaffolds with silk fibroin for bone tissue engineeringFEBS Open Bio2026Its Methods give the RRID and name the linePubMed
Exosomal CircRNA_102619-miR-330-3p Interaction Regulates Osteosarcoma Progression and Metastasis by Forming the Lung Pre-Metastatic Niche.Int J Mol Sci2026Its Methods give the RRID and name the linePubMed
An inertial-based spiral device for separating rare tumor cells from liquid biopsies.Bioeng Transl Med2026Its Methods give the RRID and name the linePubMed
Inference of lineage hierarchies, growth, and drug response mechanisms in cancer cell populations without tracking.Cell Rep Methods2026Its Methods give the RRID and name the linePubMed
Vitamin D decreases tumor cell growth and invasiveness in primary malignant bone tumors in vitro.J Bone Oncol2026Its Methods give the RRID and name the linePubMed
Combined treatment using repurposed synthetic peptide desmopressin and bevacizumab as a potential antiangiogenic strategy in osteosarcoma.Front Med (Lausanne)2026Its Methods give the RRID and name the linePubMed
Prognostic characteristics of disulfidptosis-related genes across cancers and their potential implications in osteosarcoma.Sci Prog2026Its Methods give the RRID and name the linePubMed
Ldha Regulates Osteosarcoma Lung Metastasis through Hedgehog Signaling.Cancer Res Commun2026Its Methods give the RRID and name the linePubMed
Molecular mechanism of miR-27a-3p targeting FBXW7 regulating the malignant behavior of osteosarcoma cells.Transl Cancer Res2026Its Methods give the RRID and name the linePubMed
Combined Inhibition of ATR and Ribonucleotide Reductase Induces Synergistic Antineoplastic Activity in Osteosarcoma Cells.Cancer Rep (Hoboken)2026Its Methods give the RRID and name the linePubMed

1 to 10 of 81

See all 81 papers

Relatives11

RelationCell lineAccessionProblemSource
Derived from itMG-63-GAS-Luc2CVCL_C9CXCell lines
Derived from itMG-63.3ACVCL_IR36Cell lines
Derived from itMG-63/CISR8CVCL_C6UWCell lines
Derived from itMG-63/DOXR8CVCL_C6UXCell lines
Derived from itMG-63/MTXR8CVCL_C6UYCell lines
Derived from itMG-63/TRIR8CVCL_C6UZCell lines
Derived from itMG63.2CVCL_R705Cell lines
Derived from itMG63/DXR1000CVCL_9U34Cell lines
Derived from itOSE-MG63CVCL_WR53Cell lines
Derived from itUbigene MG-63 CD276 KOCVCL_E0Z3Cell lines

Cell banks15

Cell bankCatalog numberStatusSource
ATCCCRL-1427ATCC
AddexBioC0004007/4991Cellosaurus
BCRC60279BCRC
BCRJ0173BCRJ
CCTCCGDC0074Cellosaurus
CLS300441CLS
ECACC86051601ECACC
ICLCHTL99003ICLC
IZSLERBS TCL 40Cellosaurus
JCRBIFO50108JCRB

Data dates

The date of each source this release read.

Cellosaurus
2026-10-22
Cellosaurus
PubMed Central's articles
2026-11-12
PubMed Central's articles
Our copy of PubMed
2026-11-06
Our copy of PubMed

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0426

GET https://conductscience.org/api/cell-lines/v1/CVCL_0426/papers?page=2